StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) SEC filings

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.57−0.33 (-4.78%)

Close on Nov 17, 2026Market cap $304.70MP/E –Yield –

SEC filings

19 of MapLight Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KNov 16, 2026Nov 16, 2026SEC EDGAR
Quarterly report10-QSep 30, 2026Nov 16, 2026SEC EDGAR
Current report8-KNov 16, 2026Nov 16, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 13, 2026SEC EDGAR
Current report8-KAug 13, 2026Aug 13, 2026SEC EDGAR
Current report8-KJul 27, 2026Jul 27, 2026SEC EDGAR
Current report8-KJun 23, 2026Jun 24, 2026SEC EDGAR
Current report8-KJun 22, 2026Jun 22, 2026SEC EDGAR
Current report8-KJun 18, 2026Jun 18, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KMay 14, 2026May 14, 2026SEC EDGAR
Current report8-KApr 23, 2026Apr 29, 2026SEC EDGAR
Proxy statementDEF 14AJun 23, 2026Apr 29, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 26, 2026SEC EDGAR
Current report8-KMar 26, 2026Mar 26, 2026SEC EDGAR
Current report8-KJan 9, 2026Jan 9, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Dec 4, 2025SEC EDGAR
Current report8-KDec 4, 2025Dec 4, 2025SEC EDGAR
Current report8-KOct 26, 2025Oct 29, 2025SEC EDGAR

See a number that looks wrong?